BioNTech says it is highly likely its COVID-19 vaccine can handle mutation
Published
Drug makers are scrambling to test their COVID-19 vaccines against the new fast-spreading variant of the virus that is raging in Britain, but BioNTech says it is confident its shot will provide an immune response to it.
Full Article